Immunome Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 18702 N. CREEK PARKWAY, BOTHELL, WA, 98011
Mailing Address 18702 N. CREEK PARKWAY, BOTHELL, WA, 98011
Phone 610-321-3700
Fiscal Year End 1231
EIN 770694340
Financial Overview
FY2024
$240.24M
Total Assets
$59.08M
Total Liabilities
$181.16M
Stockholders' Equity
$-5.38
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 18, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 17, 2025 | View on SEC |
| 8-K Current report of material events | December 17, 2025 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
Insider Trading
SELL 3 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.